Tirzepatide Ultima Pharmaceuticals 5mg/vial (USA Domestic)

87.00

Tirzepatide Ultima Pharmaceuticals 5mg/vial (USA Domestic) is a pharmaceutical-grade product containing the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Tirzepatide. This innovative medication has been approved for the treatment of type 2 diabetes, as it has been shown to improve glycemic control, promote weight loss, and reduce the risk of cardiovascular events in clinical trials. Manufactured in the USA by Ultima Pharmaceuticals, this high-purity Tirzepatide product offers a reliable and effective solution for healthcare providers and their patients seeking to manage type 2 diabetes.